Variables | Numbers | Percentage |
Circumstances of discovery |
|
|
Suggestive symptoms | 71 | 100 |
Complications | 0 | 0 |
Fortuitous discovery | 0 | 0 |
Functional signs |
|
|
Cholestasis syndrome |
|
|
Jaundice | 69 | 97.2 |
discolored stools | 47 | 66.2 |
Dark urine | 57 | 80.3 |
Pruritus | 45 | 63.4 |
Other functional signs |
|
|
Epigastric pain | 28 | 39.4 |
Diarrhea | 2 | 2.8 |
Weightloss | 24 | 33.8 |
Fever | 6 | 8.5 |
Melena | 2 | 2.8 |
WHO performance status |
|
|
≤2 | 39 | 54.9 |
>2 | 32 | 45.1 |
Physical signs |
|
|
Abdominal distension | 4 | 5.6 |
Hepatomegaly | 11 | 15.5 |
Abdominal mass | 4 | 5.6 |
Courvoisier Terrier’s sign | 24 | 33.8 |
ASA classification |
|
|
≤2 | 6 | 8.5 |
>2 | 65 | 91.5 |
Etiological diagnosis |
|
|
Pancreatic head cancer | 55 | 77.5 |
Extrahepatic cholangiocarcinoma | 8 | 11.3 |
Ampullary adenocarcinoma | 8 | 11.3 |
cTNM stage |
|
|
Stage I | 4 | 5.6 |
Stage II | 31 | 43.7 |
Stage III | 16 | 22.5 |
Stage IV | 20 | 28.2 |